[Effectiveness of humanized anti-interleukin-6 receptor antibody (tocilizumab) for Castleman's disease mainly with pulmonary involvement]

Nihon Naika Gakkai Zasshi. 2007 May 10;96(5):988-90. doi: 10.2169/naika.96.988.

[Article in Japanese]

Authors

Nobuhito Ohno¹, Sayuri Fujiyama, Masaomi Ooi, Kouichi Haraguchi, Masahito Tokunaga, Kimiharu Uozumi, Hirohito Tsubouchi

Affiliation

¹ Department of Digestive and Life-style related Disease, Human Environmental Sciences, Health Research Studies, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.

PMID: 17564092
DOI: 10.2169/naika.96.988

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Castleman Disease / drug therapy*
Humans
Lung Diseases / drug therapy*
Male
Middle Aged

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
tocilizumab